FDA-Drug2022-06-15Class II
MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0045-01
Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP deviations: Temperature abuse
Sold states
USA nationwide.
Affected count
796 cartons/1 vial each
Manufactured in
9954 Maryland Drive, Deep Run Iii Ste. 4000, Richmond, VA, United States
Products
MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/10 mL (40 mg/mL), 10 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0045-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1072-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief